Abstract
Purpose
Common femoral artery (CFA) is a critical segment of the lower-limb arterial tree. We sought to propose an extensive classification in order to appraise a diagnostic and therapeutic approach.
Methods
A retrospective cohort of CFA lesions with endovascular therapy was evaluated. We appraised the extension, the degree of stenosis and the calcium burden. A new group “IV” included lesions that started at the external iliac artery or common iliac artery extending into the CFA and affecting its bifurcation. The primary outcome was the need for a retrograde bailout access after failed anterograde access and the procedural time.
Results
From 2012 to 2020, a total of 58 lower limbs in patients with CFA lesions were included. New proposed group IV compromised 36% of lesions. Additionally, procedural time was significantly longer in group IV lesions compared with the rest (76.9 ± 32.23 min vs 47.67 ± 17.93 min, p < 0.01), as was the requirement of retrograde bailout access (23.8 vs 2.6%, p = 0.03). Occlusive lesions were associated with longer procedural times and bailout retrograde access compared to stenotic lesions (74.7 ± 33.6 min vs 48.29 ± 16 min, p < 0.001 and 26.1 vs 0%, p = 0.006, respectively), as well as heavy calcification compared to mild or moderate calcification (73.18 ± 28.15 vs 51.86 ± 25.1, p = 0.06 and 29.4 vs 2.4%, p = 0.009, respectively). Secondary clinical outcomes and target lesion revascularization did not differ among groups.
Conclusions
Our classification includes a new group of extensive and frequent lesions, which did not fit in previous classifications.
Similar content being viewed by others
References
Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48(4):872–7.
Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42(Suppl 2):S43-59.
Stricker H, Spinedi L, Limoni C, Giovannacci L. Stent-assisted angioplasty (SAA) at the level of the common femoral artery bifurcation: long-term outcomes. Cardiovasc Intervent Radiol. 2020;43:541–6.
Azéma L, Davaine JM, Guyomarch B, Chaillou P, Costargent A, Patra P, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41(6):787–93. https://doi.org/10.1016/j.ejvs.2011.02.025 (Epub 2011 Mar 24).
Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58(8):792–8.
Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212–20. https://doi.org/10.1002/ccd.25387 (Epub 2014 Feb 10).
Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther. 2016;23(5):731–7.
Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6.
Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60.
Martin R, Vanesa GDC, Raleigh JV, Jose C, Vadim K, Maynar M, Zander T. Common femoral artery stenting: computer tomography angiography based long-term patency. Vasc Endovascular Surg. 2021;55(6):571–6.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; Executive group on behalf of the joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) task force for the universal definition of myocardial infarction. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618-e651.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2018;49(3):e46–110.
Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931–41.
Nasr B, Della Schiava N, Thaveau F, Rosset E, Favre JP, Salomon du Mont L, et al. The common femoral artery bifurcation lesions: clinical outcome of simple versus complex stenting techniques - an analysis based on the TECCO trial. Ann Vasc Surg. 2020;64:2–10.
Sheeran D, Wilkins LR. Long chronic total occlusions: revascularization strategies. Semin Intervent Radiol. 2018;35(5):469–76.
van der Heijden FH, Eikelboom BC, Banga JD, Mali WP. Management of superficial femoral artery occlusive disease. Br J Surg. 1993;80(8):959–63.
Grözinger G, Hallecker J, Grosse U, Syha R, Ketelsen D, Brechtel K, et al. Tibiopedal and distal femoral retrograde vascular access for challenging chronic total occlusions: predictors for technical success, and complication rates in a large single-center cohort. Eur Radiol. 2021;31(1):535–42.
Giannopoulos S, Palena LM, Armstrong EJ. Technical success and complication rates of retrograde arterial access for endovascular therapy for critical limb ischaemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2021;61(2):270–9.
Boufi M, Ejargue M, Gaye M, Boyer L, Alimi Y, Loundou AD. Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment. J Vasc Surg. 2021;73(4):1445–55.
Guo J, Guo L, Tong Z, Gao X, Wang Z, Gu Y. Directional atherectomy is associated with better long-term efficiency compared with angioplasty for common femoral artery occlusive disease in Rutherford 2–4 patients. Ann Vasc Surg. 2018;51:65–71.
Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. outcomes of drug-coated balloon angioplasty vs. conventional balloon angioplasty for endovascular treatment of common femoral artery atherosclerotic disease. Cardiovasc Revasc Med. 2020; 21(7):867–874.
Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, Bollenberg L, Bisdas T. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther. 2018;25(1):92–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declared no potential conflict of interest with respect to the research, authorship and/or publication of this article.
Ethical Approval
The manuscript was approved by the Ethics committee of our Hospital.
Informed Consent
Informed consent was obtained in all patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rabellino, M., Valle Raleigh, J., Chiabrando, J.G. et al. Novel Common Femoral Artery Lesion Classification in Patients Undergoing Endovascular Revascularization. Cardiovasc Intervent Radiol 45, 438–447 (2022). https://doi.org/10.1007/s00270-021-03011-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-021-03011-z